Prediction pathway for severe asthma exacerbations: a Bayesian Network analysis.

Journal: Chest
Published Date:

Abstract

BACKGROUND: Accurate risk prediction of exacerbations is pivotal in severe asthma management. Multiple risk factors are at play, but the pathway of risk prediction remains unclear.

Authors

  • Chandra Prakash Yadav
    Saw Swee Hock School of Public Health, National University of Singapore.
  • Atlanta Chakraborty
    University of Michigan, Ann Arbor, Michigan, United States.
  • David B Price
  • Laura Huey Mien Lim
    Saw Swee Hock School of Public Health, National University of Singapore.
  • Yah Ru Juang
    Saw Swee Hock School of Public Health, National University of Singapore.
  • Richard Beasley
    Medical Research Institute of New Zealand, Wellington, New Zealand.
  • Mohsen Sadatsafavi
    Respiratory Evaluation Sciences Program, Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, BC, Canada; Division of Respiratory Medicine, Department of Medicine, The UBC Centre for Heart Lung Innovation, St. Paul's Hospital, University of British Columbia, Vancouver, BC, Canada; Institute for Heart and Lung Health, Division of Respiratory Medicine, Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada; Centre for Clinical Epidemiology and Evaluation, University of British Columbia, Vancouver, BC, Canada.
  • Christer Janson
    Department of Medical Sciences: Respiratory, Allergy and Sleep Research, Uppsala University, Uppsala, Sweden.
  • Mariko Koh Siyue
    Duke-NUS Medical School, Singapore; Department of Respiratory and Critical Care Medicine, Singapore General Hospital, Singapore.
  • Eileen Wang
  • Michael E Wechsler
    NJH Cohen Family Asthma Institute, Department of Medicine, National Jewish Health, Denver, CO, USA.
  • David J Jackson
    UK Severe Asthma Network and National Registry, Guy's and St Thomas' NHS Trust, London, UK; School of Immunology & Microbial Sciences, King's College London, London, UK.
  • John Busby
    Centre for Public Health, Queen's University Belfast, Belfast, Northern Ireland.
  • Liam G Heaney
    Wellcome-Wolfson Centre for Experimental Medicine, Queen's University Belfast, Belfast, Northern Ireland.
  • Paul E Pfeffer
    Department of Respiratory Medicine, Barts Health NHS Trust, London, UK; Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK.
  • Bassam Mahboub
    Clinical Sciences Department, College of Medicine, University of Sharjah, Sharjah P.O. Box 27272, United Arab Emirates.
  • Diahn-Warng Perng Steve
    Division of Clinical Respiratory Physiology Chest Department, Taipei Veterans General Hospital, Taipei City, Taiwan; COPD Assembly of the Asian Pacific Society of Respirology, Tokyo, Japan.
  • Borja G Cosío
    Department of Respiratory Medicine, Hospital Universitario Son Espases-IdISBa, Palma de Mallorca, Spain.
  • Luis Perez-de-Llano
    Pneumology Service, Lucus Augusti University Hospital, EOXI Lugo, Monforte, Cervo; Biodiscovery Research Group, Health Research Institute of Santiago de Compostela, Spain.
  • Riyad Al-Lehebi
    Department of Pulmonology, King Fahad Medical City, Riyadh, Saudi Arabia; College of Medicine, Alfaisal University, Riyadh, Saudi Arabia.
  • Désirée Larenas-Linnemann
    Centro de Excelencia en Asma y Alergia, Hospital Médica Sur, Ciudad de México, Mexico.
  • Mona S Al-Ahmad
    Microbiology Department, College of Medicine, Kuwait University, Al-Rashed Allergy Center, Ministry of Health, Kuwait.
  • Chin Kook Rhee
    Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, South Korea.
  • Takashi Iwanaga
    Sleep Medicine Centre, Kindai University Hospital, Osakasayama, Japan.
  • Enrico Heffler
    Personalized Medicine, Asthma and Allergy, Humanitas Clinical and Research Center IRCCS, Rozzano, Milan, Italy; Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy.
  • Giorgio Walter Canonica
    Personalized Medicine, Asthma and Allergy, Humanitas Clinical and Research Center IRCCS, Rozzano, Milan, Italy; Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy.
  • Richard W Costello
    Clinical Research Centre, Smurfit Building Beaumont Hospital, Department of Respiratory Medicine, RCSI, Dublin, Ireland.
  • Nikolaos G Papadopoulos
    Allergy and Clinical Immunology Laboratory, Second Department of Pediatrics, National and Kapodistrian University of Athens (NKUA), School of Medicine, P. and A. Kyriakou Children's Hospital, Athens, Greece.
  • Andriana I Papaioannou
    2nd Respiratory Medicine Department, National and Kapodistrian, University of Athens Medical School, Attikon University Hospital, Athens, Greece.
  • Celeste M Porsbjerg
    Respiratory Research Unit, Bispebjerg University Hospital, Copenhagen, Denmark; Allergy, Asthma & Clinical Immunology Service, Alfred Health, Melbourne, Australia.
  • Carlos A Torres-Duque
    CINEUMO, Respiratory Research Center, Fundación Neumológica Colombiana, Bogotá, Colombia.
  • George C Christoff
    Medical University-Sofia, Faculty of Public Health, Sofia, Bulgaria.
  • Todor A Popov
    Clinic of Occupational Diseases, University Hospital Sveti Ivan Rilski, Sofia, Bulgaria.
  • Mark Hew
    Allergy, Asthma & Clinical Immunology Service, Alfred Health, Melbourne, Australia; Public Health and Preventive Medicine, Monash University, Melbourne, Australia.
  • Matthew J Peters
    Department of Thoracic Medicine, Concord Hospital, Sydney, Australia.
  • Peter G Gibson
    Australian Severe Asthma Network, Priority Research Centre for Healthy Lungs, University of Newcastle, Newcastle, Australia; Hunter Medical Research Institute, Department of Respiratory and Sleep Medicine, John Hunter Hospital, New Lambton Heights, Australia.
  • Jorge Máspero
    Clinical Research for Allergy and Respiratory Medicine, CIDEA Foundation, Buenos Aires, Argentina; University Career of Specialists in Allergy and Clinical Immunology, Buenos Aires University School of Medicine, Buenos Aires, Argentina.
  • Celine Bergeron
    Centre for Lung Health, Vancouver General Hospital, University of British Columbia, Vancouver, British Columbia, Canada.
  • Saraid Cerda
    Medical Specialties Unit, Secretary of National Defense, Mexico City, Mexico.
  • Elvia Angelica Contreras
    Mexican Council of Clinical Immunology and Allergy, Mexico City Office, Mexico City, Mexico; Department of Allergy and Clinical Immunology, Lic. Adolfo López Mateos Regional Hospital of the Institute of Security and Social Services for State Workers (ISSSTE), Mexico City, Mexico.
  • Wenjia Chen
    Respiratory Evaluation Sciences Program, Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, BC, Canada.

Keywords

No keywords available for this article.